Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bone Marrow Transplantation

  Free Subscription


Articles published in Biol Blood Marrow Transplant

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    May 2019
  1. PRATA PH, Resche-Rigon M, Blaise D, Socie G, et al
    Outcomes of Salvage Haploidentical Transplant with Post-transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Biol Blood Marrow Transplant. 2019 May 23. pii: S1083-8791(19)30324.
    PubMed     Text format     Abstract available


    January 2019
  2. MEIER JA, Haque M, Fawaz M, Abdeen H, et al
    T Cell Repertoire Evolution After Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
    Biol Blood Marrow Transplant. 2019 Jan 21. pii: S1083-8791(19)30072.
    PubMed     Text format     Abstract available


  3. GEORGES GE
    Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia.
    Biol Blood Marrow Transplant. 2019 Jan 11. pii: S1083-8791(19)30064.
    PubMed     Text format    


    December 2018
  4. MCCURDY SR, Kanakry CG, Tsai HL, Gojo I, et al
    Development of Grade II Acute Graft-Versus-Host Disease is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
    Biol Blood Marrow Transplant. 2018 Dec 30. pii: S1083-8791(18)31700.
    PubMed     Text format     Abstract available


    November 2018
  5. DE LA FUENTE J, Dhedin N, Koyama T, Bernaudin F, et al
    Haploidentical bone marrow transplant with post-transplant cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an international learning collaborative.
    Biol Blood Marrow Transplant. 2018 Nov 27. pii: S1083-8791(18)30772.
    PubMed     Text format     Abstract available


    October 2018
  6. ATSUTA Y, Kato S, Morishima Y, Ohashi K, et al
    Comparison of HLA allele mismatch and antigen mismatch in unrelated bone marrow transplantation in patients with leukemia.
    Biol Blood Marrow Transplant. 2018 Oct 8. pii: S1083-8791(18)30611.
    PubMed     Text format     Abstract available


  7. PALMER J, Scherber R, Girardo M, Geyer H, et al
    Patient Perspectives Regarding Allogeneic Bone Marrow Transplant in Myelofibrosis.
    Biol Blood Marrow Transplant. 2018 Oct 3. pii: S1083-8791(18)30600.
    PubMed     Text format     Abstract available


    July 2018
  8. DEZERN AE, Jones RJ, Brodsky RA
    Eculizumab Bridging Before Bone Marrow Transplant for Marrow Failure Disorders is Safe and Does Not Limit Engraftment.
    Biol Blood Marrow Transplant. 2018 Jul 25. pii: S1083-8791(18)30421.
    PubMed     Text format     Abstract available


  9. T BO, H G, N BA, A L, et al
    "Filgrastim following HLA-identical allogeneic bone marrow transplantation: long-term outcomes of a randomized trial".
    Biol Blood Marrow Transplant. 2018 Jul 20. pii: S1083-8791(18)30413.
    PubMed     Text format     Abstract available


    June 2018
  10. BAI L, Best G, Xia W, Peters L, et al
    Expression of intracellular reactive oxygen species (ROS) in haematopoietic stem cells (HSCs) correlates with time to neutrophil and platelet engraftment in patients undergoing autologous bone marrow transplantation.
    Biol Blood Marrow Transplant. 2018 Jun 19. pii: S1083-8791(18)30326.
    PubMed     Text format     Abstract available


  11. KATSANIS E, Sapp LN, Varner N, Koza S, et al
    Haploidentical bone marrow transplantation with post-transplant cyclophosphamide/bendamustine in pediatric and young adult patients with hematologic malignancies.
    Biol Blood Marrow Transplant. 2018 Jun 13. pii: S1083-8791(18)30319.
    PubMed     Text format     Abstract available


  12. KANAKRY CG, Luznik L
    Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform.
    Biol Blood Marrow Transplant. 2018;24:1108-1110.
    PubMed     Text format    


  13. CHIUSOLO P, Bug G, Olivieri A, Brune M, et al
    A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study.
    Biol Blood Marrow Transplant. 2018;24:1243-1249.
    PubMed     Text format     Abstract available


  14. SHENOY S, Walters MC, Ngwube A, Soni S, et al
    Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
    Biol Blood Marrow Transplant. 2018;24:1216-1222.
    PubMed     Text format     Abstract available


    April 2018
  15. DEVADASAN D, Sun CW, Westin ER, Wu LC, et al
    Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
    Biol Blood Marrow Transplant. 2018 Apr 21. pii: S1083-8791(18)30192.
    PubMed     Text format     Abstract available


    March 2018
  16. KUSUDA M, Kimura SI, Misaki Y, Yoshimura K, et al
    Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation.
    Biol Blood Marrow Transplant. 2018 Mar 5. pii: S1083-8791(18)30110.
    PubMed     Text format     Abstract available


  17. ANAND S, Sarantopoulos S
    Chronic Graft-versus-Host Disease: A Long Road Ahead.
    Biol Blood Marrow Transplant. 2018;24:423-424.
    PubMed     Text format    


  18. QAYED M, Wang T, Hemmer MT, Spellman S, et al
    Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
    Biol Blood Marrow Transplant. 2018;24:521-528.
    PubMed     Text format     Abstract available


    February 2018
  19. ELMARIAH H, Kasamon YL, Zahurak M, Macfarlane KW, et al
    Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors.
    Biol Blood Marrow Transplant. 2018 Feb 13. pii: S1083-8791(18)30083.
    PubMed     Text format     Abstract available


  20. BURGER DR, Parker Y, Guinta K, Lindner D, et al
    PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Ry(null) Mice.
    Biol Blood Marrow Transplant. 2018;24:260-266.
    PubMed     Text format     Abstract available


  21. FUREY A, Rastogi S, Prince R, Jin Z, et al
    Bone Marrow Harvest in Pediatric Sibling Donors: Role of Granulocyte Colony-Stimulating Factor Priming and CD34(+) Cell Dose.
    Biol Blood Marrow Transplant. 2018;24:324-329.
    PubMed     Text format     Abstract available


  22. MCCURDY SR, Kanakry CG, Tsai HL, Kasamon YL, et al
    Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.
    Biol Blood Marrow Transplant. 2018;24:343-352.
    PubMed     Text format     Abstract available


    January 2018
  23. KASAMON YL, Fuchs EJ, Zahurak M, Rosner GL, et al
    Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation.
    Biol Blood Marrow Transplant. 2018 Jan 17. pii: S1083-8791(18)30026.
    PubMed     Text format     Abstract available


  24. OLSSON RF
    Self-Destructive Behavior among Full-Donor Blood and Marrow Grafts and the Association with Long-Term Graft Function.
    Biol Blood Marrow Transplant. 2018;24:1-2.
    PubMed     Text format    


  25. MIKULSKA M, Raiola AM, Galaverna F, Balletto E, et al
    Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
    Biol Blood Marrow Transplant. 2018;24:109-118.
    PubMed     Text format     Abstract available


    November 2017
  26. CIRILLO M, Tan P, Sturm M, Cole C, et al
    Cellular Immunotherapy for Haematological Malignancies: Beyond Bone Marrow Transplant.
    Biol Blood Marrow Transplant. 2017 Nov 1. pii: S1083-8791(17)30804.
    PubMed     Text format     Abstract available


    October 2017
  27. RAIOLA AM, Risitano A, Sacchi N, Giannoni L, et al
    Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High Dose Cyclophosphamide.
    Biol Blood Marrow Transplant. 2017 Oct 9. pii: S1083-8791(17)30757.
    PubMed     Text format     Abstract available


    August 2017
  28. LLOSA NJ, Cooke KR, Chen A, Gamper C, et al
    Reduced Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.
    Biol Blood Marrow Transplant. 2017 Aug 11. pii: S1083-8791(17)30634.
    PubMed     Text format     Abstract available


  29. UGAI T, Kanda Y, Morishima Y, Matsuo K, et al
    Role of Genetic Polymorphism of ALDH2 in Hematopoietic Stem Cell Transplantation.
    Biol Blood Marrow Transplant. 2017;23:1374-1380.
    PubMed     Text format     Abstract available


    July 2017
  30. IMUS PH, Blackford AL, Bettinotti M, Iglehart B, et al
    Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplant.
    Biol Blood Marrow Transplant. 2017 Jul 25. pii: S1083-8791(17)30605.
    PubMed     Text format     Abstract available


    May 2017
  31. KUREKCI E, Kupesiz A, Anak S, Ozturk G, et al
    Hematopoietic Stem Cell Transplantation Using Preimplantation Genetic Diagnosis and Human Leukocyte Antigen Typing for Human Leukocyte Antigen-Matched Sibling Donor: A Turkish Multicenter Study.
    Biol Blood Marrow Transplant. 2017;23:790-794.
    PubMed     Text format     Abstract available


  32. LIU HD, Ahn KW, Hu ZH, Hamadani M, et al
    Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
    Biol Blood Marrow Transplant. 2017;23:767-775.
    PubMed     Text format     Abstract available


  33. HASHMI SK, Bredeson C, Duarte RF, Farnia S, et al
    National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.
    Biol Blood Marrow Transplant. 2017;23:717-725.
    PubMed     Text format     Abstract available


    March 2017
  34. DEZERN AE, Zahurak M, Symons H, Cooke K, et al
    Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.
    Biol Blood Marrow Transplant. 2017;23:498-504.
    PubMed     Text format     Abstract available


  35. GRAVES SS, Rezvani A, Sale G, Stone D, et al
    A Canine Model of Chronic Graft-versus-Host Disease.
    Biol Blood Marrow Transplant. 2017;23:420-427.
    PubMed     Text format     Abstract available


    February 2017
  36. MIYAMOTO T, Fukuda T, Nakashima M, Henzan T, et al
    Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program.
    Biol Blood Marrow Transplant. 2017 Feb 17. pii: S1083-8791(17)30281.
    PubMed     Text format     Abstract available


  37. AL-HOMSI AS, Goodyke A, McLane M, Abdel-Mageed S, et al
    Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone.
    Biol Blood Marrow Transplant. 2017;23:255-261.
    PubMed     Text format     Abstract available


  38. SANO H, Hilinski JA, Applegate K, Chiang KY, et al
    African American Race Is a Newly Identified Risk Factor for Postengraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation.
    Biol Blood Marrow Transplant. 2017;23:357-360.
    PubMed     Text format     Abstract available


  39. PATRIARCA F, Cigana C, Massimo D, Lazzarotto D, et al
    Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Biol Blood Marrow Transplant. 2017;23:333-339.
    PubMed     Text format     Abstract available


  40. MALARD F, Labopin M, Stuhler G, Bittenbring J, et al
    Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the Europea
    Biol Blood Marrow Transplant. 2017;23:278-284.
    PubMed     Text format     Abstract available


  41. LANGE S, Steder A, Killian D, Knuebel G, et al
    Engraftment Efficiency after Intra-Bone Marrow versus Intravenous Transplantation of Bone Marrow Cells in a Canine Nonmyeloablative Dog Leukocyte Antigen-Identical Transplantation Model.
    Biol Blood Marrow Transplant. 2017;23:247-254.
    PubMed     Text format     Abstract available


    January 2017
  42. CHEN YB, Efebera YA, Johnston L, Ball ED, et al
    Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.
    Biol Blood Marrow Transplant. 2017 Jan 16. pii: S1083-8791(17)30194.
    PubMed     Text format     Abstract available


  43. MAJZNER RG, Mogri H, Varadhan R, Brown P, et al
    Post-Transplant Cyclophosphamide after Bone Marrow Transplantation is Not Associated with an Increased Risk of Donor Derived Malignancy.
    Biol Blood Marrow Transplant. 2017 Jan 3. pii: S1083-8791(17)30065.
    PubMed     Text format     Abstract available


    November 2016
  44. KLEIN OR, Buddenbaum J, Tucker N, Chen AR, et al
    Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.
    Biol Blood Marrow Transplant. 2016 Nov 22. pii: S1083-8791(16)30516.
    PubMed     Text format     Abstract available


  45. YOKOYAMA H, Kanda J, Fuji S, Kim SW, et al
    Impact of HLA allele mismatch in unrelated bone marrow transplantation with reduced intensity conditioning regimen.
    Biol Blood Marrow Transplant. 2016 Nov 11. pii: S1083-8791(16)30487.
    PubMed     Text format     Abstract available


  46. BONFIM C, Ribeiro L, Nichele S, Loth G, et al
    Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.
    Biol Blood Marrow Transplant. 2016 Nov 7. pii: S1083-8791(16)30484.
    PubMed     Text format     Abstract available


    October 2016
  47. PATTON WN, Nivison-Smith I, Bardy P, Dodds A, et al
    Graft Transit Time Has No Effect on Outcome of Unrelated Donor Haematopoietic Cell Transplants Performed in Australia and New Zealand: a Study From the Australasian Bone Marrow Transplant Recipient Registry.
    Biol Blood Marrow Transplant. 2016 Oct 4. pii: S1083-8791(16)30389.
    PubMed     Text format     Abstract available


    May 2016
  48. KUMAR R, Kimura F, Ahn KW, Hu ZH, et al
    Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
    Biol Blood Marrow Transplant. 2016;22:932-40.
    PubMed     Text format     Abstract available


    April 2016
  49. LANGE S, Steder A, Glass A, Killian D, et al
    Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Biol Blood Marrow Transplant. 2016;22:637-43.
    PubMed     Text format     Abstract available


  50. KANDA J, Brazauskas R, Hu ZH, Kuwatsuka Y, et al
    Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations.
    Biol Blood Marrow Transplant. 2016;22:744-51.
    PubMed     Text format     Abstract available


  51. MERKEL EC, Mitchell SA, Lee SJ
    Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
    Biol Blood Marrow Transplant. 2016;22:752-8.
    PubMed     Text format     Abstract available


  52. BUCK K, Wadsworth K, Setterholm M, Maiers M, et al
    High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry.
    Biol Blood Marrow Transplant. 2016;22:759-63.
    PubMed     Text format     Abstract available


    March 2016
  53. REDDY P, Cutler C
    Selected Reviews from the 2016 BMT Tandem Meetings.
    Biol Blood Marrow Transplant. 2016;22.
    PubMed     Text format    


    February 2016
  54. TERAKURA S, Atsuta Y, Tsukada N, Kobayashi T, et al
    Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.
    Biol Blood Marrow Transplant. 2016;22:330-8.
    PubMed     Text format     Abstract available


  55. YOUNG JA, Logan BR, Wu J, Wingard JR, et al
    Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
    Biol Blood Marrow Transplant. 2016;22:359-70.
    PubMed     Text format     Abstract available


  56. GUIEZE R, Damaj G, Pereira B, Robin M, et al
    Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.
    Biol Blood Marrow Transplant. 2016;22:240-7.
    PubMed     Text format     Abstract available


    January 2016
  57. JACOBY E, Chen A, Loeb DM, Gamper CJ, et al
    Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.
    Biol Blood Marrow Transplant. 2016;22:112-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bone Marrow Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: